A geocentric approach to pharmaceutical Research and development and drug regulatory affairs

Jach W. Reich, Daniel E. Hilleman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A new approach to world-wide pharmaceutical research and development and drug regulatory affairs is described. This new geocentric approach centers around a view of the entire industrialized world as an array of potential sites for research and development activities. Chosing specific sites for research and development activities involves detailed assessment of local regulatory affairs and economies-of-scale. The geocentric approach represents a step forward from the legal and economic forces which have constrained the pharmaceutical industry through the decades of the 1960s and 1970s. In order to realized the full potential of this approach, the establishment of a multinational liason group between industry and governmental drug regulatory bodies is proposed.

Original languageEnglish
Pages (from-to)1-22
Number of pages22
JournalClinical Research and Regulatory Affairs
Volume3
Issue number1
DOIs
StatePublished - 1985

Fingerprint

Research
Pharmaceutical Preparations
Drug Industry
Economics
Pharmaceutical Research

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Pharmacology
  • Pharmacology (medical)

Cite this

A geocentric approach to pharmaceutical Research and development and drug regulatory affairs. / Reich, Jach W.; Hilleman, Daniel E.

In: Clinical Research and Regulatory Affairs, Vol. 3, No. 1, 1985, p. 1-22.

Research output: Contribution to journalArticle

@article{9ca0d8d56aab41af8a1f671dd7a2b798,
title = "A geocentric approach to pharmaceutical Research and development and drug regulatory affairs",
abstract = "A new approach to world-wide pharmaceutical research and development and drug regulatory affairs is described. This new geocentric approach centers around a view of the entire industrialized world as an array of potential sites for research and development activities. Chosing specific sites for research and development activities involves detailed assessment of local regulatory affairs and economies-of-scale. The geocentric approach represents a step forward from the legal and economic forces which have constrained the pharmaceutical industry through the decades of the 1960s and 1970s. In order to realized the full potential of this approach, the establishment of a multinational liason group between industry and governmental drug regulatory bodies is proposed.",
author = "Reich, {Jach W.} and Hilleman, {Daniel E.}",
year = "1985",
doi = "10.3109/10601338509051046",
language = "English",
volume = "3",
pages = "1--22",
journal = "Clinical Research Practices and Drug Regulatory Affairs",
issn = "1060-1333",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - A geocentric approach to pharmaceutical Research and development and drug regulatory affairs

AU - Reich, Jach W.

AU - Hilleman, Daniel E.

PY - 1985

Y1 - 1985

N2 - A new approach to world-wide pharmaceutical research and development and drug regulatory affairs is described. This new geocentric approach centers around a view of the entire industrialized world as an array of potential sites for research and development activities. Chosing specific sites for research and development activities involves detailed assessment of local regulatory affairs and economies-of-scale. The geocentric approach represents a step forward from the legal and economic forces which have constrained the pharmaceutical industry through the decades of the 1960s and 1970s. In order to realized the full potential of this approach, the establishment of a multinational liason group between industry and governmental drug regulatory bodies is proposed.

AB - A new approach to world-wide pharmaceutical research and development and drug regulatory affairs is described. This new geocentric approach centers around a view of the entire industrialized world as an array of potential sites for research and development activities. Chosing specific sites for research and development activities involves detailed assessment of local regulatory affairs and economies-of-scale. The geocentric approach represents a step forward from the legal and economic forces which have constrained the pharmaceutical industry through the decades of the 1960s and 1970s. In order to realized the full potential of this approach, the establishment of a multinational liason group between industry and governmental drug regulatory bodies is proposed.

UR - http://www.scopus.com/inward/record.url?scp=84907036836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907036836&partnerID=8YFLogxK

U2 - 10.3109/10601338509051046

DO - 10.3109/10601338509051046

M3 - Article

VL - 3

SP - 1

EP - 22

JO - Clinical Research Practices and Drug Regulatory Affairs

JF - Clinical Research Practices and Drug Regulatory Affairs

SN - 1060-1333

IS - 1

ER -